BGLC vs WRK
BioNexus Gene Lab Corp Common stock (BGLC) versus WRK (WRK) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
WRK (WRK) common stock.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
WRK does not have a complete income-statement cache yet.
BGLC currently screens at market cap $6.1M.
Not investment advice. Open the BGLC and WRK stock pages for the full models.
Not investment advice.